INCR
InterCure Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$5.31
+0.00%Latest reported
- Last report date
- Oct 3, 2024
- EPS actual
- $0.03
- EPS estimate
- —
- Revenue actual
- $14.9M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -68.4%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 3, 2024 | — | $0.03 | — | $14.9M |
| Aug 30, 2024 | — | $0.00 | — | $16.7M |
| May 1, 2024 | — | $0.00 | — | $17.0M |
| Mar 29, 2024 | — | $0.05 | — | $20.3M |
| Aug 31, 2023 | $0.05 | $0.03 | Miss -40.00% | $27.7M |
| May 15, 2023 | $0.08 | $0.01 | Miss -87.50% | $29.6M |
| Mar 31, 2023 | — | $0.05 | — | $30.6M |
| Nov 15, 2022 | $0.32 | $0.05 | Miss -84.38% | $28.3M |
| Aug 15, 2022 | $0.26 | $0.10 | Miss -61.54% | $27.3M |
| May 16, 2022 | $0.24 | $0.11 | Miss -54.17% | $27.3M |
| Nov 15, 2021 | $0.15 | -$0.01 | Miss -106.67% | $19.1M |
| Aug 16, 2021 | $0.14 | $0.12 | Miss -14.29% | $13.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jul 30, 2026